Ikarian Capital »

Voyager Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Voyager Therapeutics (VYGR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Voyager Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Voyager Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Voyager Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 306k 8.44
2023-09-30 $2.4M 306k 7.75
2023-06-30 $3.4M 300k 11.45

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Voyager Therapeutics

EcoR1 Capital
Vanguard Group
T. Rowe Price Associates
Dimensional Fund Advisors
AQR Capital Management
Federated Investors
D. E. Shaw & Co
Jpmorgan Chase & Co
Ikarian Capital
Fiduciary Trust Company
Bank of New York Mellon
Kestra Advisory Services
ADAR1 Capital Management
Goldman Sachs Group
TD Asset Management

View all funds holding Voyager Therapeutics